DCAT Benchmarking Study Provides Insight into Supply-Chain Challenges

05/28/20 • 14 min

DCAT Value Chain Insights’ Production to Prescription

In this podcast, we feature an article about a recent DCAT Benchmarking study, conducted prior to COVID-19, that provides insights on whether biopharma companies and their suppliers believe the deteriorating trade environment is a major threat, and what they are doing to confront the real and potential risks to their supply chains. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

Examining trade-related risks
Study's background
Sources of supply-chain risk
Awareness of supply-chain risk
Managing supply-chain risks
US market scenarios
Vulnerable industry supply chains

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Support the show

Key topics: (see Chapter Markers)

Examining trade-related risks
Study's background
Sources of supply-chain risk
Awareness of supply-chain risk
Managing supply-chain risks
US market scenarios
Vulnerable industry supply chains

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Support the show

Previous Episode

Pharma Company on the Move: The New AbbVie

In this podcast, we feature an article that examines the new AbbVie, including the key products and expanded manufacturing networking, resulting from its recent acquisition of Allergan. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

Inside the deal
Inside the new AbbVie

Links:

Subscribe to our e-newsletter at www.dcatvci.org

Support the show

Next Episode

Tracking Expansion in High-Potency Manufacturing

In this podcast, we round up key recent expansions in high-potency manufacturing by CDMOs and CMOs. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)